New Approach to Validation
New Approach
to Validation
01 AUTOMATION:
USFDA supports and encourages automation as it has the
potential to improve productivity and efficiency, help in tracking and
trending, plus a host of other benefits.
Manufacturers can gain advantages from automation throughout
the entire product lifecycle. They can reduce or eliminate human errors,
optimize resources, and reduce patient risk.
USFDA’s position is
that using these software products can be an excellent way to enhance product
quality and patient safety, which in the end, is the overarching goal.
02 CHANGING THE PARADIGM:
Current industry practice as part of CSV program is
documentation heavy. Documentation is done at the expense of critical thinking
and testing.
CSA brings paradigm shift in this approach by encouraging
critical thinking over documentation. By using CSA concepts, companies can
execute more testing with less documentation based on risk associated with
requirement.
03 LEVERAGE VENDOR DOCUMENTATION:
Perform vendor assessment and based on outcome leverage
vendor executed testing during designing the validation strategy of the
product. If the vendor demonstrates, a strong QMS then the validation strategy
can be optimized to validate the delta and high-risk scenarios.
04 RISK RATING:
CSA recommends the following streamlined risk assessment
process, which aims to perform risk-based testing at requirement level (refer
section 7 for more details) This simplified approach includes only two
variables: • Requirement’s potential impact on product quality and patient
safety. • Implementation method of the Requirement.
05 UNSCRIPTED TESTING:
Unscripted testing liberates a tester from following
click-by-click level test script and allows the tester to conduct free-form
testing and documenting the results. Unscripted testing includes Ad-hoc and
Exploratory Testing (refer section 8 for more details)
“Trust but Verify “ Ronald Reagan
Across the internet, there are millions of resources are available which provide information about Everything.
If you found all content under one roof then it will save your time, effort & you will more concentrated on your important activity.
![]() |
Data Integrity App |
Our Data integrity app will helpful for understanding what Data integrity & CSV really means & How 21 CFR Part 11, EU Annex 11 & other regulatory guidelines affects in pharmaceutical Industry.
- Basic Data Integrity Concepts
- ERES & Its Requirement
- CSV & Its best practices
- Mock Inspection and General Q&A
- Checklist for inspection
- Inspection Readiness
- Useful SOP’s
- Stay Regulatory Compliant.
“Stay One Step Ahead in Pharma IT Compliance”
https://play.google.com/store/apps/details?id=com.innovativeapps.dataintegrity
Try our "Data Integrity" app which helps you to better understand current regulatory agencies thinking on Data Integrity & CSV.
Comments
Post a Comment